Personale docente

Present affiliation:

address:Section of Dermatology, Department of Medicine and Surgery
        University of Parma
        Via Gramsci 14
        IT-43124 Parma
        Italy
telephone:    +39 0521 033574
fax:        +39 0521 702323
e-mail:        sergio.dinuzzo@ unipr.it

Education:
1996-2000      Ph.D., University of Amsterdam UVA, Amsterdam, The Netherlands.
1991-1995    Specialisation in Dermatology, University of Parma, Parma, Italy.
1982-1989    M.D. Diploma, University of Napoli Federico II, Napoli, Italy.

Fellowships, grants and additional training:
2002    One year Master-Allergology, University of Perugia, Perugia, Italy
1996    Three months fellowship supported by funds from the NUFFIC (Netherlands organisation for international co-operation in higher education). “Effects of UVB on cutaneous T cells”. Department of Dermatology, University of Amsterdam, Amsterdam, The Netherlands.
1994    Nine months fellowship supported by funds from the European Community ERASMUS Program. “Effects of solar-simulated UV light on cutaneous T cells”. Department of Dermatology, University of Amsterdam, Amsterdam, The Netherlands.
1990    One-year Master-Vascular disease, University of Napoli Federico II, Napoli, Italy.
    Six months internship at the Department of Dermatology, Hospital of Caserta, Caserta, Italy.
1986-1989    Internship at the Department of Dermatology, University of Napoli Federico II.

Employment experiences:
2006-to date    Permanent staff Member, Section of Dermatology, Department of Medicine and Surgery, University of Parma.
2000- 2005    Postdoctoral Research Fellow, Department of Dermatology, University of Parma. Private Practice, Dermatology
1996-2000    Research Fellow, Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
1991-1995    Resident in training, Department of Dermatology, University of Parma.
1990-1991    General Practitioner, Caserta, Italy.

Teaching experiences:
2006- to date    Lecturer, Dermatology, School of Medicine, University of Parma.
    Lecturer, Dermatology, School of Dentistry, University of Parma.
    Lecturer, Skin biotechnology, School of Biotechnology, University of Parma
2000- 2006    Lecturer, Photoimmunodermatology, Department of Dermatology, University of Parma.
    Resident and Student Tutor, Department of Dermatology, University of Parma.
1996-2000    Student Tutor, Photoimmunology Group, Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
 1990-1991    Lecturer, Normal Human Anatomy, Nurses School of Caserta, Caserta, Italy.

Clinical Trials (as principal investigator):
2018   Study “DIMESKIN 2” Sponsor Galderma
Study BMS-986165 :a Multi-Center,Randomized,Double-Blind,Placebo- and Active Comparator-Controlled Phase 3 study with an Introduction Period Followed by Randomized Maintenance Period to Evaluate the  Clinical Efficacy and Safety of BMS-986165 IN Subjects with Moderate to Severe Psoriasis. Sponsor Brystol-Meyers Squibb
2017  Study “CAIN457A2310”: a randomized,double- blind , placebo- and active controlled multicenter trial to demonstrate efficacy of subcutaneous secukinumab compared to placebo and Etanercept (in a single-blinded arm) after twelve weeks of treatment,and to assess the safety,tolerability,and long-term efficacy in subjects from 6 to less than 18 years of age with severe chronic plaque psoriasis”.  Sponsor Pfeizer
2016  Studio”RD.06.SPR..18132” Sponsor Galderma.
2015     Studies  “RD.06.SPR.18131” Sponsor Galderma, and  “Cain457AIT01”: Sponsor Novartis.
2014  Study  “Vaccines and Diagnostics”: AH5N1 Sponsor Novartis.
2013 Studies SCH900222/MK-3222: studies tildrakizumab (SCH900222/MK-3222) SC, Sponsor Merck Sharp & Dohme Corporation.
2012    Study ‘PSO-TOP’: Dovobet® Gel. Sponsor Leo Pharma.
Study “IDIF”: “Studio osservazionale, prospettico, multicentrico sull’approccio terapeutico topico nella psoriasi del cuoio capelluto di grado lieve moderato”. Sponsor IDI.  
Study “ETANERCEPT cod.08881x1.4535WW”. Sponsor Pfizer Italia.
2011     Study “GENDER ATTENTION”: Sponsor Novartis Farma.
2010    Study  “SYNERGY”, Observational StudY of INfectious Events in PsoRiasis complicated bY Active Psoriatic Arthrithis. Sponsor Novartis.
2008    Study  “SCORE”, Sustained Ciclosporin Outcome Replacing Etanercept. Sponsor Wyeth Lederle S.p.A.
2007     Study  “PRESTA”, Psoriasis Randomized Etanercept Study in Subjects with Psoriatic Arthritis, Sponsor Wyeth Lederle S.p.A.
2002    Study “PSYCHAE”, Psoriasis SurveyY for the Control of tHe Anxiety. Sponsor Novartis.

Major research interests:
1.    Photoimmunology
2.    Skin Cancer Immunosurveillance
3.    Phototherapy
4.    Psoriasis, Atopic Dermatitis and Vitiligo
5.    Clinical Photodermatology

Languages:
Italian:        native speaker
English:    fluent
Dutch:        fair